Sarclisa (isatuximab-irfc) for the Treatment of Multiple Myeloma

Sarclisa is an anti-CD3 monoclonal antibody that attacks multiple myeloma cancer cells. Credit: Sanofi-Aventis.



  • Sarclisa
  • Sarclisa
  • Sarclisa
  • Sarclisa